CRKL (CRK like proto-oncogene, adaptor protein)

2003-02-01  

Identity

HGNC
LOCATION
22q11.21
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 1399
MIM: 602007
HGNC: 2363
Ensembl: ENSG00000099942

Variants:

dbSNP: 1399
ClinVar: 1399
TCGA: ENSG00000099942
COSMIC: CRKL

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000099942ENST00000354336P46109
ENSG00000099942ENST00000411769P46109

Expression (GTEx)

0
10
20
30
40
50
60
70
80

Pathways

PathwaySourceExternal ID
MAPK signaling pathwayKEGGko04010
ErbB signaling pathwayKEGGko04012
Focal adhesionKEGGko04510
Regulation of actin cytoskeletonKEGGko04810
Insulin signaling pathwayKEGGko04910
Renal cell carcinomaKEGGko05211
Chronic myeloid leukemiaKEGGko05220
MAPK signaling pathwayKEGGhsa04010
ErbB signaling pathwayKEGGhsa04012
Focal adhesionKEGGhsa04510
Regulation of actin cytoskeletonKEGGhsa04810
Insulin signaling pathwayKEGGhsa04910
ShigellosisKEGGhsa05131
Pathways in cancerKEGGhsa05200
Renal cell carcinomaKEGGhsa05211
Chronic myeloid leukemiaKEGGhsa05220
Chemokine signaling pathwayKEGGko04062
Chemokine signaling pathwayKEGGhsa04062
Neurotrophin signaling pathwayKEGGko04722
Neurotrophin signaling pathwayKEGGhsa04722
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
Bacterial invasion of epithelial cellsKEGGko05100
Bacterial invasion of epithelial cellsKEGGhsa05100
MicroRNAs in cancerKEGGhsa05206
MicroRNAs in cancerKEGGko05206
Rap1 signaling pathwayKEGGhsa04015
Rap1 signaling pathwayKEGGko04015
Immune SystemREACTOMER-HSA-168256
Cytokine Signaling in Immune systemREACTOMER-HSA-1280215
Signaling by InterleukinsREACTOMER-HSA-449147
Interleukin-3, 5 and GM-CSF signalingREACTOMER-HSA-512988
Regulation of signaling by CBLREACTOMER-HSA-912631
Signal TransductionREACTOMER-HSA-162582
Signalling by NGFREACTOMER-HSA-166520
NGF signalling via TRKA from the plasma membraneREACTOMER-HSA-187037
Signalling to ERKsREACTOMER-HSA-187687
Prolonged ERK activation eventsREACTOMER-HSA-169893
Frs2-mediated activationREACTOMER-HSA-170968
Signaling by PDGFREACTOMER-HSA-186797
Downstream signal transductionREACTOMER-HSA-186763
Signaling by METREACTOMER-HSA-6806834
MET promotes cell motilityREACTOMER-HSA-8875878
MET activates RAP1 and RAC1REACTOMER-HSA-8875555
MET receptor recyclingREACTOMER-HSA-8875656

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
380528582024Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis.3
383872292024Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD.0
384030272024CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.0
386831312024CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.0
380528582024Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis.3
383872292024Exploring the short linear motif-mediated protein-protein interactions of CrkL through ProP-PD.0
384030272024CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.0
386831312024CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.0
371214462023Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism.1
371214462023Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism.1
335235622021CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt.4
335614432021Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.1
341146852021Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling.1
341964582021Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome.4
342098122021Bifunctional Role of CrkL during Bone Remodeling.1

Citation

Dessen P

CRKL (CRK like proto-oncogene, adaptor protein)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/40150/img/img/logo-atlas-4.svg